JP2023538030A - 新規の調節放出性経口避妊用組成物 - Google Patents

新規の調節放出性経口避妊用組成物 Download PDF

Info

Publication number
JP2023538030A
JP2023538030A JP2023511588A JP2023511588A JP2023538030A JP 2023538030 A JP2023538030 A JP 2023538030A JP 2023511588 A JP2023511588 A JP 2023511588A JP 2023511588 A JP2023511588 A JP 2023511588A JP 2023538030 A JP2023538030 A JP 2023538030A
Authority
JP
Japan
Prior art keywords
composition
dng
contraceptive
oral
hours
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023511588A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023538030A5 (enExample
Inventor
エンリコ コッリ
Original Assignee
キーモ リサーチ エセ．エレ．
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by キーモ リサーチ エセ．エレ． filed Critical キーモ リサーチ エセ．エレ．
Publication of JP2023538030A publication Critical patent/JP2023538030A/ja
Publication of JP2023538030A5 publication Critical patent/JP2023538030A5/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/2853—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers, poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Inorganic Chemistry (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
JP2023511588A 2020-08-14 2021-08-13 新規の調節放出性経口避妊用組成物 Pending JP2023538030A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP20382753.0A EP3954364A1 (en) 2020-08-14 2020-08-14 New modified release oral contraceptive composition
EP20382753.0 2020-08-14
PCT/EP2021/072584 WO2022034209A1 (en) 2020-08-14 2021-08-13 New modified release oral contraceptive composition

Publications (2)

Publication Number Publication Date
JP2023538030A true JP2023538030A (ja) 2023-09-06
JP2023538030A5 JP2023538030A5 (enExample) 2024-08-13

Family

ID=72145348

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023511588A Pending JP2023538030A (ja) 2020-08-14 2021-08-13 新規の調節放出性経口避妊用組成物

Country Status (21)

Country Link
US (3) US12409141B2 (enExample)
EP (2) EP3954364A1 (enExample)
JP (1) JP2023538030A (enExample)
KR (1) KR20230067614A (enExample)
CN (1) CN116322701A (enExample)
AU (1) AU2021325372A1 (enExample)
BR (1) BR112023002654A2 (enExample)
CA (1) CA3191326A1 (enExample)
CL (1) CL2023000450A1 (enExample)
CO (1) CO2023002874A2 (enExample)
CR (1) CR20230127A (enExample)
DO (1) DOP2023000029A (enExample)
EC (1) ECSP23016038A (enExample)
IL (1) IL300578A (enExample)
JO (1) JOP20230032A1 (enExample)
MX (1) MX2023001868A (enExample)
PE (1) PE20231378A1 (enExample)
PY (1) PY2168235A (enExample)
UY (1) UY39379A (enExample)
WO (1) WO2022034209A1 (enExample)
ZA (1) ZA202303273B (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20260021110A1 (en) * 2024-07-18 2026-01-22 Chemo Research, S.L. Methods of oral contraception by controlled release of dienogest and ethynyl estradiol
WO2026146125A1 (en) 2024-12-30 2026-07-09 Chemo Research, S.L. Treatment of hirsutism, polycystic ovarian syndrome and other associated conditions

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002504069A (ja) * 1995-07-26 2002-02-05 ドゥラメド ファーマシューティカルズ，インコーポレーテッド 複合エストロゲンの医薬組成物およびその使用方法
JP2008527019A (ja) * 2005-02-15 2008-07-24 バイエル・シエーリング・ファーマ アクチエンゲゼルシャフト 固体経口避妊薬
JP2009501747A (ja) * 2005-07-20 2009-01-22 グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング トリメゲストンによる経口避妊
JP2011530499A (ja) * 2008-08-08 2011-12-22 バイエル ファーマ アクチエンゲゼルシャフト プロゲスチンを含有する薬物送達システム

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5340585A (en) 1991-04-12 1994-08-23 University Of Southern California Method and formulations for use in treating benign gynecological disorders
US7589082B2 (en) 2003-06-13 2009-09-15 Skendi Finance Ltd Pharmaceutical formulation for contraception and hormone-replacement therapy
EP1690529A1 (de) 2005-02-15 2006-08-16 Schering AG Feste perorale Arzneiform zur Kontrazeption, die Dienogest und Ethinylestradiol enthält

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002504069A (ja) * 1995-07-26 2002-02-05 ドゥラメド ファーマシューティカルズ，インコーポレーテッド 複合エストロゲンの医薬組成物およびその使用方法
JP2008527019A (ja) * 2005-02-15 2008-07-24 バイエル・シエーリング・ファーマ アクチエンゲゼルシャフト 固体経口避妊薬
JP2009501747A (ja) * 2005-07-20 2009-01-22 グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング トリメゲストンによる経口避妊
JP2011530499A (ja) * 2008-08-08 2011-12-22 バイエル ファーマ アクチエンゲゼルシャフト プロゲスチンを含有する薬物送達システム

Also Published As

Publication number Publication date
UY39379A (es) 2022-01-31
CO2023002874A2 (es) 2023-04-05
CR20230127A (es) 2023-06-23
MX2023001868A (es) 2023-05-09
CN116322701A (zh) 2023-06-23
US12409141B2 (en) 2025-09-09
DOP2023000029A (es) 2023-07-09
IL300578A (en) 2023-04-01
PE20231378A1 (es) 2023-09-07
US20260027058A1 (en) 2026-01-29
AU2021325372A1 (en) 2023-03-30
EP3954364A1 (en) 2022-02-16
US12409142B2 (en) 2025-09-09
CL2023000450A1 (es) 2023-10-20
WO2022034209A1 (en) 2022-02-17
JOP20230032A1 (ar) 2023-02-13
ECSP23016038A (es) 2023-04-28
EP4196098A1 (en) 2023-06-21
US20240041775A1 (en) 2024-02-08
BR112023002654A2 (pt) 2023-04-04
ZA202303273B (en) 2026-02-25
PY2168235A (es) 2022-04-25
US20240350415A1 (en) 2024-10-24
CA3191326A1 (en) 2022-02-17
KR20230067614A (ko) 2023-05-16

Similar Documents

Publication Publication Date Title
US20260027058A1 (en) New modified release oral contraceptive composition
KR20210013663A (ko) 드로스피레논을 포함하는 약학적 조성물 및 피임용 키트
US12478630B2 (en) Method for treating endometriosis and providing effective contraception
RU2261106C2 (ru) Гормональная композиция на основе гестагена и эстрогена и ее применение
US20260021110A1 (en) Methods of oral contraception by controlled release of dienogest and ethynyl estradiol
OA21171A (en) New modified release oral contraceptive composition.
US8426392B2 (en) Method for providing emergency contraception
HK40096856A (en) New modified release oral contraceptive composition
BR122025022756A2 (pt) Composição contraceptiva oral de liberação modificada, seu uso, seu processo de obtenção e kit contraceptivo
US20260053817A1 (en) Progestogen-only oral contraception
US20250186337A1 (en) Chewable oral contraceptive
KR102210982B1 (ko) 드로스피레논을 포함하는 약학적 조성물 및 피임용 키트
HK40111725A (en) Method for treating endometriosis and providing effective contraception
HK40108056A (en) Progestogen-only oral contraception
EA049724B1 (ru) Пероральная контрацепция с использованием только прогестагенов
EA046645B1 (ru) Фармацевтические препараты для лечения эндометриоза, миомы матки, синдрома поликистоза яичников или аденомиоза
CN106265694A (zh) 用于过重女性患者的基于屈螺酮的避孕药

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20230410

RD01 Notification of change of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7426

Effective date: 20230410

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20240802

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20240802

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20250723

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20250812

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20251111

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20260224

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20260324

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20260519

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20260716